March 02, 2020
The Business Group submitted comments supporting HHS's proposals regarding drug manufacturer coupons and the ACA's limitations on cost-sharing.
Comment Letter on 2021 Notice of Benefit and Payment Parameters
More Topics
Policy & Advocacy Pharmacy/Prescription DrugsMore in Policy & Advocacy